Healthcare & Medical Investment Corporation, the Tokyo-listed real estate trust known by its ticker as R-HCM, has raised its earnings outlook for the period to January 2027 by double digits, and told unitholders their payout per unit will not move. The REIT lifted its operating revenue forecast 17.8% to ¥3.52bn and its net profit forecast 24.0% to ¥1.63bn, driven by a 14-property acquisition and a debt-funded expansion. The distribution per unit for that period stays exactly where the REIT last forecast it: ¥3,440.
| Metric | Previous forecast | Revised forecast | Change |
|---|---|---|---|
| Operating revenue | ¥2.98bn | ¥3.52bn | +17.8% |
| Operating profit | ¥1.65bn | ¥2.05bn | +24.3% |
| Net profit | ¥1.31bn | ¥1.63bn | +24.0% |
| Distribution per unit | ¥3,440 | ¥3,440 | 0% |
The reason profit and payout have decoupled is dilution. R-HCM's board approved a public offering of 92,858 new units plus a third-party allotment of up to 4,642 units to underwriter SMBC Nikko Securities, lifting the outstanding unit count from 359,500 to as many as 457,000, an increase of more than a quarter. The offering is expected to raise up to ¥10.1bn, which will help fund a ¥21.7bn purchase of 14 healthcare properties, backed by a fresh ¥10.5bn loan from qualified institutional investors.
The shopping list includes a ground lease under a 99-bed Shinjuku hospital known for emergency care, priced at ¥3.44bn, plus 13 senior-care facilities, including nursing homes, serviced-housing complexes and a dementia-care group home, across Sapporo, Yokohama, Osaka and greater Tokyo, for a combined ¥21.7bn against a combined appraisal value of ¥24.9bn. Thirteen of the fourteen properties are being bought from parties related to the asset manager's sponsor network. The manager, Healthcare Asset Management, says its compliance committee and investment committee reviewed and approved the related-party transactions on August 18 and 19.
The payout picture shifts again the following half. For the period to July 2027, R-HCM forecasts net profit of ¥1.20bn and a total distribution of ¥3,170 per unit, down from the flat ¥3,440 set for the prior period. Of that July total, ¥417 per unit is a separate distribution in excess of earnings, while the remaining ¥2,753 ordinary distribution is boosted by releasing roughly ¥53mn that R-HCM plans to set aside as a tax reserve from a separate property sale: the REIT expects to book a ¥344mn gain in January 2027 from selling a care facility in Tokyo's Shinagawa ward for ¥2.19bn, and under a tax provision for replacing long-held assets, it will bank part of that gain rather than pay it out immediately, adding it back to net profit for the following period's ordinary distribution instead.
The acquisitions push R-HCM's portfolio from 57 properties worth ¥86.6bn to 70 properties worth ¥106.6bn, taking it past the ¥100bn asset-scale target it set when it listed in 2015 and, by its own comparison against rival J-REITs' disclosed portfolios as of June 2026, making it the largest healthcare-focused REIT on the Tokyo exchange by property value. Loan-to-value is expected to rise modestly, to 50.9% at the end of January 2027 and 51.1% by July, as total interest-bearing debt climbs from ¥46.6bn to ¥55.1bn after refinancing maturing loans.
The numbers remain forecasts. The public offering's issue price had not been set as of the disclosure date, the third-party allotment could shrink if SMBC Nikko does not take up its full allocation, and R-HCM's own filings flag that further property acquisitions, disposals, interest-rate moves or market shifts could change the outcome before either period closes.